Observ Prosp Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in Belarus

Clinical trial NCT07288515 · RECRUITING

Trial details

NCT number: NCT07288515
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia

Start date: 2025-12-31
Primary completion: 2029-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.